Table 5.
Demographic features, clinical profile and maternal outcomes of pregnant women with fever by three most common aetiologies
| Total (n = 181) n (%) | Dengue (n = 44) n (%) | Hepatitis E (n = 26) n (%) | UTI (n = 22) n (%) | |
|---|---|---|---|---|
| Primigravida # | 80 (44.2) | 17 (38.6) | 11 (42.3) | 13 (59) |
| Gestational age (weeks)* | 30 (6–40) | 31 (10–40) | 31 (12–39) | 29 (6–39) |
| Duration of fever (days)* | 6 (2–60) | 4 (2–10) | 7 (3–14) | 6 (2–30) |
| Temperature at admission (°F)* | 101.4 (99–104) | 100.6 (99–102) | 100.3 (99–104) | 100.8 (99.6–103) |
| Haemoglobin (g/dL)** | 10 (5–16) | 11 (7.3–14.2) | 11 (7.6–13.6) | 10.3 (6.8–13.3) |
| Total leucocyte count (per µL)** | 11,900 (2400–41,300) | 8350 (3200–24,000) | 14,650 (3200–34,400) | 18,900 (4400–29,200) |
| Platelet count (lacs/ µL)** | 1.7 (0.1–8.3) | 0.97 (0.05–3.8) | 1.85 (0.49–3.2) | 2.1 (0.6–8.3) |
| Creatinine (mg/dL)** | 0.6 (0.2–28) | 0.6 (0.2–28) | 0.7 (0.4–20) | 0.65 (0.3–6.8) |
| AST (IU/L)** | 79 (15–10,547) | 78 (26–10,547) | 537 (51–7775) | 48 (15–224) |
| ALT (IU/L)** | 54 (5–5083) | 54 (15–3521) | 568 (100–5083) | 48 (5–278) |
| PTI (%)** | 100 (10–100) | 100 (33–100) | 65 (19–86) | 100 (56–100) |
| ARDS # | 28 (15.5) | 8 (18.2) | 2 (7.6) | 0 |
| AKI # | 41 (22.6) | 8 (18.2) | 6 (23.1) | 5 (22.8) |
| ALF # | 40 (22.1) | 4 (9.1) | 21 80.7) | 1 (4.5) |
| Encephalopathy# | 34 (18.8) | 5 (11.4) | 8 (30.7) | 0 |
| WHO maternal near miss # | 33 (18.2) | 7 (16) | 9 (34.6) | 4 (18.2) |
| Duration of hospital stay (days)* | 7 (1–52) | 9 (1–52) | 7 (1–12) | 8 (1–27) |
| Maternal death# | 29 (16) | 7 (16) | 6 (23.1) | 0 |
AKI Acute kidney injury, ALF acute liver failure, ALT alanine transaminase, ARDS acute respiratory distress syndrome, AST aspartate transaminase, PTI prothrombin index, LSCS lower segment caesarean section, UTI urinary tract infection
#Percentage; denominator = n (Dengue = 44, Hepatitis E = 26, UTI = 22)
*Average (minimum value–maximum value)
**Median (minimum value–maximum value)